Exagen XGN reported its Q1 earnings results on Monday, May 15, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Exagen beat estimated earnings by 21.43%, reporting an EPS of $-0.44 versus an estimate of $-0.56.
Revenue was up $836 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.27 which was followed by a 2.13% drop in the share price the next day.
Here's a look at Exagen's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | -0.78 | -0.73 | -0.57 | -0.61 |
EPS Actual | -0.51 | -0.47 | -0.78 | -0.60 |
Revenue Estimate | 8.66M | 9.13M | 12.04M | 10.00M |
Revenue Actual | 12.84M | 14.73M | 8.96M | 10.39M |
To track all earnings releases for Exagen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.